AZ CEO Pascal Soriot recorded an interview with PharmaDispatch during his recent trip to Australia.
In the first of a two-part interview, he discusses the new AstraZeneca, his personal affinity with 'home' in Australia and how it 'breaks his heart' governments here have not done more to grow innovative industries.
AZ's Pascal Soriot: 'My Australia and the new AstraZeneca'
January 31, 2019 BioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Potential merger could create a new global oncology powerhouse
August 3, 2026 - - Latest News -
First new brain cancer treatment listed on PBS after more than 20 years
August 3, 2026 - - Latest News -
The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants
August 3, 2026 - - Latest News -
Listing offers treatment option for Australians with tumour induced osteomalacia
August 3, 2026 - - Latest News -
Funding for new chemotherapy-free immunotherapy combination for follicular lymphoma
August 3, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 31 July
July 31, 2026 - - Podcast -
New partnership aims to create national blueprint for earlier Alzheimer’s diagnosis and care
July 31, 2026 - - Latest News